Delivery Order SPE2DB24D2109-SPE2DB24FHVVH

Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,863.89 firm fixed-price delivery order is for the supply of 4,564,603,718 units of Ondansetron ODT 4 mg tablets in 30-count packages. The contract has a completion date of May 15, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,566,811,993 units of Ondansetron ODT 8 mg tablets in 30-count packages. The $8,982.21 firm-fixed-price delivery order contract has an ultimate completion date of December 31, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,841.28 firm fixed-price delivery order is for the supply of 4565047871 Ondansetron ODT 4 mg tablets. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,854.35 firm fixed-price delivery order is for 4,562,881,717 units of the drug Ondansetron ODT 4 mg tablets. This award is part of Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,739.22 firm fixed price delivery order is for the supply of Ondansetron ODT 8 mg tablets. The contract has an ultimate completion date of September 20, 2023. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,555,923 units of Ondansetron ODT 8 mg tablets. The $3,156.38 firm-fixed-price delivery order has a completion date of November 27, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,098.88 firm fixed-price delivery order is for the supply of Ondansetron ODT 8 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,626.35, is for the delivery of Ondansetron ODT 4 mg tablets in quantities of 30 per package. The contract is a Firm Fixed Price Delivery Order with a completion date of March 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ondansetron ODT 8 mg tablets. The contract has a firm fixed price of $1,271.26 and an ultimate completion date of October 9, 2024. This is a delivery order contract, which is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,249.02 firm fixed-price delivery order contract is for the provision of 4,567,155,720 units of Ondansetron ODT 8 mg tablets. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
  • SPE2DB24D2109
    Indefinite Delivery Contract
  • SPE2DB24D2109-SPE2DB24FHVVH
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4565134720 units of Ondansetron ODT 8 mg tablets. The $4,367.24 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This award represents a small portion of the extensive medical commodities covered under AmerisourceBergen's DLA IDC, which includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/17/25, 9:52 AM